CompoAtlas

BREAKOUT CONTROL TARGETED BLEMISH SPOT SOLUTION

Natural health product licensed in Canada

Licence holder
Kiehl's Canada
NPN or DIN-HM
80086637
Status
Inactive licence
Licence date
26 June 2018
Revision date
Not provided
Form
Solution
Route of administration
Topique
Application type
Officinale

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal composition not provided.

Non-medicinal ingredients

Lécithine hydrogénée, Stéarate de PEG-100, Phényléthyle résorcinol, Acétate de dl-alpha tocophéryle, Silicate de magnésium et d'aluminium, Phénoxyéthanol, Jus de feuilles d'Aloe Barbadensis, Édétate disodique, Alcool stéarylique, Myristate de 2-octyldodécyle, Hydroxyde de sodium, Amidon de Zea Mays (maïs), Isoparaffine en C13 à 14, Ethylhexylglycérine, Aqua, Acide glycolique, Allantoïne, Poly(acrylamide), Extrait de racine de Glycyrrhiza Glabra (Réglisse), Alcool cétéarylique, Cétéareth-20, Niacinamide, Laureth-7, Glycérine

PopulationAgeQuantity per servingFrequency
Sous-population S/ONot specified1 Portion(s)minimum: 1 Tous les jours ; maximum: 3 Tous les jours

Uses authorised in Canada

For the treatment/management of acne. Helps reduce the acne pimples.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80086637

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line